COVID-19

Analysis: Long COVID's Cost on personal lives and the economy

Mon, 2024-10-21 21:02 — mike kraft

How Much Does Long COVID Cost Society? New Data Shed Light Economic estimates are rising as more long COVID case data become clear. Experts weigh the fixes. David Brzostowicki Medscape

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Analysis: Long COVID's Cost on personal lives and the economy
Log in or register to post comments

Evaluating this year’s COVID booster as a good match for new variants

Mon, 2024-10-21 20:51 — mike kraft

Is this year’s COVID booster a good match for new variants? Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to dominate this fall and winter. amartichoux The Hill

...

While they may not be a perfect match, the latest variants have enough in common with the KP.2 and JN.1 that the boosters should still offer effective cross-protection.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Evaluating this year’s COVID booster as a good match for new variants
Log in or register to post comments

Explainer: Vaccination side effects and what they indicate

Sat, 2024-10-19 04:40 — mike kraft

What Vaccine Side Effects Really Mean And is it bad not to have side effects after a shot? Jamie Ducharme TIME

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Explainer: Vaccination side effects and what they indicate
Log in or register to post comments

Long COVID symptoms: Study assesses 'symptom diary' of trial participants

Fri, 2024-10-18 21:19 — mike kraft

Search continues for treatment that reduces long COVID symptoms: Study assesses 'symptom diary' of trial participants The first randomized, placebo-controlled clinical trial evaluating the impact of therapeutic monoclonal antibodies on the risk of developing long COVID was led by researchers at Weill Cornell Medicine. ... Weill Cornell Medical College Medical Xpress

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Long COVID symptoms: Study assesses 'symptom diary' of trial participants
Log in or register to post comments

How a heavily minority Maryland county initiative successfully improved COVID-19 vaccine rates --study

Wed, 2024-10-16 21:16 — mike kraft

Research initiative successfully combats COVID-19 vaccine disparities An innovative effort to close the gap in COVID-19 vaccination rates in Prince George's County, Maryland found major success, according to new research co-authored by a public health leader at Kennedy ... Kennedy Krieger Institute Medical Xpress

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Solutions

Situation Report

Novavax's trial of combo COVID-flu shot put on hold because of safety concerns

Wed, 2024-10-16 20:56 — mike kraft

US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after one person who received the shot reported nerve damage, the company said on Wednesday. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about Novavax's trial of combo COVID-flu shot put on hold because of safety concerns
Log in or register to post comments

Three doses of mRNA COVID vaccine show advantage against severe outcomes --study

Wed, 2024-10-16 20:41 — mike kraft

3 doses of mRNA COVID vaccine show advantage against severe outcomes The authors said COVID-19 infection can result in a "brainstem insult" that results in clusters of physical long-COVID symptoms. CIDRAP

A team led by US Food and Drug Administration (FDA) researchers studying Medicare claims data during the early Omicron SARS-CoV-2 variant months conclude that a third dose of mRNA COVID-19 vaccine provides significant protection against hospitalization and death compared with two doses but wanes substantially after 4 months.

...

Country / Region Tags:

General Topic Tags: